Three treatments for psoriatic arthritis are recommended in final draft guidance published by the National Institute of Health and Clinical Excellence (NICE). Etanercept (Enbrel), infliximab (Remicade) and adalimumab (Humira) are proposed for treating adults with active and progressive psoriatic arthritis when specified criteria are met. Following the public consultation in March this year on ...

NICE (The National Institute for Health and Clinical Excellence) has recommended Enbrel� (etanercept) as a treatment option for adults with active and progressive psoriatic arthritis. NICE makes recommendations to the NHS (National Health Service) on new and existing medicines, treatments and procedures, and treating and caring for people with specific diseases and conditions. For UK patients a ...

BRIDGMAN -- According to the Centers for Disease Control and Prevention, 46 million adults suffer from some form of arthritis while 294,000 children, or 1 in 250, have been diagnosed with the condition.

According to the Center for Disease Control, arthritis is the most common cause of disability in the United States, affecting an estimated 46 million adults. Although the most common form of arthritis, osteoarthritis, is typified by painful swelling and stiffness in the joints, is a fact of life for many older men and women, a majority of arthritis sufferers are under the age 65. Arthritis ...

Hundreds are expected to show up and don't for a minute think arthritis is only a problem for adults.